Army Working on Precision Strike Missile Increment 5Francis' 23 lead NJIT over Navy 69-64Just about everyone dreams about cars they wish they could own, and there’s no better time than the holidays to make a list of vehicles you’d love to have in your driveway. The car pros at Edmunds rounded up five of their favorite dream-worthy vehicles. But rather than just list the most outlandish and expensive exotics, they focused on highlighting models that are expensive but not so pricey that it’d be completely unrealistic for you to own one one day. The vehicles are ordered in ascending order of price and include destination fees. Off-road trucks look fantastic and are extremely capable. What truck enthusiast wouldn’t have one topping their wish list? The king of the hill for 2025 is the F-150 Raptor R. The regular Raptor is already impressive, and the R takes it to the next level with a bonkers 720-horsepower supercharged 5.2-liter V8 engine, upgraded Fox dual-value shock absorbers, and massive 37-inch all-terrain tires. An R-specific grille and hood are also part of the R’s upgrades. Thankfully, the Raptor R isn’t all bark and bite. It also has plenty of features to make it a livable truck for daily driving. Standard features include leather upholstery, cooling front seats, a premium sound system, and a surround-view camera to help make this big truck easier to park. Starting Price: $112,825 Few sedans can match the Mercedes-Benz S-Class for opulence, luxury and prestige. This grand sedan showcases nearly every luxury, technology and performance innovation that Mercedes-Benz has concocted. Everything you touch inside is likely covered in leather, heated, or bathed in disco-worthy ambient light. A novel could be written about all of the S-Class’ luxury and comfort features, but one of the most notable is the E-Active Body Control system. It scans the road surface ahead and adjusts the suspension to deliver the best ride possible. The S-Class also boasts an extensive list of advanced safety features and has an augmented reality head-up display that projects images that appear to float in front of the car. For the ultimate S-Class, get the 791-horsepower AMG S 63 E Performance model. Starting Price: $118,900 Who needs a European exotic car when the Corvette ZR1 is just as capable? A sports car fanatic’s wish list wouldn’t be right without the ZR1. The new Corvette hit a record-setting top speed of 233 mph, making it the fastest car ever built by an American automaker and the fastest current production car priced under $1 million, according to Chevrolet. The top speed record was possible thanks to the ZR1’s turbocharged 5.5-liter V8 engine that cranks out a staggering 1,064 horsepower. Its carbon-fiber aero package kept it glued to the track by generating over 1,200 pounds of downforce at top speed. Chevrolet also says the ZR1 can accelerate through the quarter mile in less than 10 seconds. We expect the Corvette ZR1 to go on sale in early 2025. Estimated starting price: $150,000 Does your wish list include a big and powerful SUV? If it does, the Escalade-V should top it. The big Caddy roars like a muscle car thanks to its supercharged 6.2-liter V8 that churns out 682 horsepower and helps it hit 60 mph in just 4.4 seconds. The Escalade-V also boasts enormous 24-inch wheels and large Brembo brakes that help bring the three-ton SUV to a stop. But the Escalade-V isn’t only about brute power. It also has three rows of seating, plenty of cargo space and offers impressive tech like Super Cruise, a hands-free highway driving system, and an enormous 55-inch curved display that spans the dashboard. Starting Price: $161,990 What if we told you there was a car that could outpace almost anything on a drag strip, keep up with high-end sports cars on a racetrack, and be comfortable enough for daily errands? Well, if that sounds amazing, add the Air Sapphire to your dream list. The Air Sapphire is a high-performance electric luxury sedan made by Lucid, an electric vehicle startup. It’s one of the most powerful production cars in the world, producing an astonishing 1,234 horsepower from its three electric motors. Lucid says it has a top speed of 205 mph and can rocket to 60 mph in a mind-numbing 1.9 seconds. You can adjust the vehicle’s setting for exceptional track performance or simply provide a comfortable ride around town. Starting price: $250,500 Edmunds says Even if you can’t afford any of these vehicles, you can still picture one sitting in your driveway or imagine yourself cruising around town in it. And who knows, maybe holiday magic will give you the opportunity to own one in the future.
NASHUA, N.H., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Further to a release issued under the same headline on November 26, 2024 13:00 ET by iCAD, Inc., the headline and fourth paragraph have been updated to acknowledge a pending trademark application for the mark “SecondReadAI” by Lunit, Inc. The corrected release follows: iCAD, Inc . (NASDAQ: ICAD) (“iCAD” or the “Company”), a global leader in clinically proven AI-powered cancer detection solutions, will showcase its groundbreaking breast health AI technologies at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago, December 1-5. Key highlights include the recent FDA-cleared ProFound Detection Version 4, clinical research presentations, and a new partnership with Cascaid Health to expand access to AI-driven breast health solutions. iCAD and Cascaid Health Partner to Expand Access to AI-Driven Breast Health In alignment with their vision to enable all women to access to AI-powered breast health services, iCAD and Cascaid Health will unveil their collaboration to integrate the ProFound AI Breast Health Suite into Cascaid’s leading edge digital health marketplace and access to care platform. Scheduled for beta launch in Q1 2025, this partnership between iCAD and Cascaid Health will launch ProFound Health, a virtual care model powered by Cascaid. ProFound Health will enable women who have not otherwise received an AI-read on their screening mammogram to access iCAD’s advanced breast health technology. The initiative reflects both companies’ dedication to democratizing access to life-saving technology and creating a world where cancer can’t hide. ProFound Health partnership will offer virtual second reads of mammograms leveraging ProFound AI Breast Health Suite, an AI service providing patients without access to AI an opportunity to receive enhanced breast health insights. The initial service will include a second read detection, breast density assessment, and cancer risk evaluation from a Cascaid-affiliated specialist network of clinical experts in women’s health through Cascaid’s seamlessly integrated digital platform. By combining AI insights with expert clinical reviews, ProFound Health ensures that patients everywhere, regardless of location, can receive precision screening and personalized care. “ProFound Health empowers patients with access to critical information about their mammograms and overall breast health, allowing them to make informed decisions and take control of their care journey,” said Dana Brown, CEO and President of iCAD. “Our collaboration with Cascaid Health’s network of clinicians and AI-powered solutions is part of our ongoing commitment to bridging gaps in breast cancer care, ensuring all patients everywhere can access the accuracy and timeliness of AI solutions, and ultimately transforming patient outcomes.” “We believe that every woman should have access to the best possible information about her breast health and a high quality, personalized care plan to catch cancer early or prevent it altogether. Through our partnership with iCAD, we’re addressing a critical need to improve access to advanced breast health services,” said Dr. Candace Westgate, Director of Women’s Health for Cascaid Health. “ProFound Health is more than just a technological innovation, it’s a lifeline that empowers patients and healthcare providers with actionable insights, bridging care gaps and ensuring equitable access to precision screening and personalized breast cancer care.” Advancing Next Generation AI Breast Health Solutions at RSNA 2024 In addition to ProFound Health, iCAD will feature its flagship ProFound Detection Version 4.0, which recently received FDA clearance. This next-generation AI solution enhances breast cancer detection by incorporating prior exams into current analysis, improving the detection of aggressive cancers by 22%, reducing cases with no marks by 18%, and providing clinicians with more reliable insights for better decision-making. “Every two minutes, someone loses their life to breast cancer—a disease affecting over 2.3 million women annually. Early detection is critical, as five-year survival rates exceed 99% for stage 1 disease. Yet traditional mammography misses over 20% of breast cancers, particularly in dense tissue, resulting in potentially avoidable late-stage diagnoses,” said Dana Brown, President and CEO of iCAD, Inc. “ProFound Detection Version 4 revolutionizes breast cancer detection by uniquely integrating prior exams into its analysis. This advanced capability enhances sensitivity, sharpens precision, and provides radiologists with a deeper, longitudinal view of a patient’s breast health. By enabling earlier and more accurate detection, especially in dense tissue, ProFound Detection Version 4 sets a new standard in breast health AI, empowering providers to improve outcomes and save lives. Together with our strategic partnerships, we are advancing the fight against cancer and making a meaningful difference for patients worldwide.” ICAD’S RSNA 2024 Program Highlights AI-Powered Insights: Advancing Cancer Detection Oral Abstract Presentation : “Real World Effect of Artificial Intelligence on Histopathology and Stage in Breast Cancer Screening” Presenter : Kathy Schilling, M.D., Boca Raton Regional Hospital When : Sunday, December 1 | 10:30–11:30 AM Where : S406A: S2-SSBR01-6 Details : Dr. Kathy Schilling discusses the experience with tenured radiologists on how the current use of ProFound AI improves cancer detection, even in women with dense breast tissue, compared to their performance prior to the implementation of AI. In addition, she will describe the decrease in the mean size and stage of cancers after the implementation, along with an increase in the diagnosis of lobular cancers. “The integration of ProFound AI alongside our nine dedicated breast radiologists has demonstrated remarkable improvements in cancer detection and patient outcomes across our imaging network,” said Dr. Kathy Schilling, Medical Director of the Christine E. Lynn Women’s Health & Wellness Institute at Boca Raton Regional Hospital. “We’ve seen a 23% overall increase in cancer detection rates, a 4% rise in invasive cancer detection, and doubled rates of lobular cancer detection. ProFound AI also enhanced detection in dense breast tissue by 32%, reduced invasive cancer size by 12%, and lowered histopathologic stage with a 40% reduction in T2 tumors—all without increasing DCIS diagnoses or recall rates. These advancements underscore the transformative potential of AI in improving early breast cancer detection, elevating patient care, and ultimately saving lives.” AI Theater Presentation : “The Thin White Line: Which Calcifications Matter? Advances in AI Breast Cancer Detection” Presenter : Chirag R. Parghi, M.D., M.B.A., Solis Mammography When : Tuesday, December 3 | 1:00–1:20 PM Where : AI Showcase Theater (South Hall A), Booth 5536 Details : A look at how ProFound Detection’s next-generation capabilities reduce uncertainty in interpreting calcifications on a mammogram by displaying 20% fewer marks related to vascular calcifications and 51% fewer marks related to non-vascular calcifications, leading to enhanced precision and accuracy. Collaborative Panels and Partner Showcases GE HealthCare Expert Corner : Seamless integration of ProFound AI with GE mammography systems to enhance workflow and detection capabilities. Daily at Booth 7330 (North Hall). Densitas Panel : “Elevating Patient Care through Quality Images & Precise Detection.” Daily at Booth 4747 (South Hall). CancerIQ : Daily at Booth 4747(South Hall). Blackford Panel : “Enhancing Breast Cancer Care with AI.” Tuesday, December 3, 2:30-2:50 PM at Booth 4729 (South Hall). CARPL.ai Breast AI Panel : Wednesday, December 4, 11:00 AM at Booth 5733 (South Hall). Customer Appreciation Event iCAD will be hosting a customer appreciation event, "AI in the Sky: Discover ProFound Insights & Breast Health Innovations," on Sunday, December 1, at 6:00 PM at VU Rooftop in Chicago. Network with industry experts, hear insights from key opinion leaders including iCAD’s CEO and Board of Directors, and explore how iCAD’s solutions are transforming breast health. Visit the iCAD RSNA 2024 event page for the latest updates, event details, and partnership announcements. About Cascaid Health Cascaid Health Inc. delivers a personalized, expert-driven proactive and preventative approach, supported by an integrated platform designed to promote longevity, detect issues early, reverse risks, and optimize healthspan for all. The company’s platform offers a curated marketplace featuring innovative products, services, and access to world-class multidisciplinary experts in women’s health, precision health, lifestyle medicine, wellness, and performance. Cascaid Health Inc. is committed to advancing health equity, ensuring that cutting-edge healthcare solutions are accessible to everyone. About iCAD, Inc. iCAD, Inc. (NASDAQ: ICAD) is a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and improve patient outcomes. Headquartered in Nashua, N.H., iCAD’s industry-leading ProFound Breast Health Suite provides AI-powered mammography analysis for breast cancer detection, density assessment and risk evaluation. Used by thousands of providers serving millions of patients, ProFound is available in over 50 countries. In the last five years alone, iCAD estimates reading more than 40 million mammograms worldwide, with nearly 30% being tomosynthesis. For more information, including the latest in regulatory clearances, please visit www.icadmed.com . Forward-Looking Statements Certain statements contained in this News Release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about the expansion of access to the Company’s products, improvement of performance, acceleration of adoption, expected benefits of ProFound AI®, the benefits of the Company’s products, and future prospects for the Company’s technology platforms and products. Such forward-looking statements involve a number of known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of the Company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited, to the Company’s ability to achieve business and strategic objectives, the willingness of patients to undergo mammography screening, whether mammography screening will be treated as an essential procedure, whether ProFound AI will improve reading efficiency, improve specificity and sensitivity, reduce false positives and otherwise prove to be more beneficial for patients and clinicians, the impact of supply and manufacturing constraints or difficulties on our ability to fulfill our orders, uncertainty of future sales levels, to defend itself in litigation matters, protection of patents and other proprietary rights, product market acceptance, possible technological obsolescence of products, increased competition, government regulation, changes in Medicare or other reimbursement policies, risks relating to our existing and future debt obligations, competitive factors, the effects of a decline in the economy or markets served by the Company; and other risks detailed in the Company’s filings with the Securities and Exchange Commission. The words “believe,” “demonstrate,” “intend,” “expect,” “estimate,” “will,” “continue,” “anticipate,” “likely,” “seek,” and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release. For additional disclosure regarding these and other risks faced by iCAD, please see the disclosure contained in our public filings with the Securities and Exchange Commission, available on the Investors section of our website at https://www.icadmed.com and on the SEC’s website at http://www.sec.gov . CONTACTS Media Inquiries: pr@icadmed.com Investor Inquiries: John Nesbett/Rosalyn Christian IMS Investor Relations icad@imsinvestorrelations.comAfter a sprawling hacking campaign exposed the communications of an unknown number of Americans, U.S. cybersecurity officials are advising people to use encryption in their communications. To safeguard against the risks highlighted by the campaign, which originated in China, federal cybersecurity authorities released an extensive list of security recommendations for U.S. telecom companies — such as Verizon and AT&T — that were targeted. The advice includes one tip we can all put into practice with our phones: “Ensure that traffic is end-to-end encrypted to the maximum extent possible.” End-to-end encryption, also known as E2EE, means that messages are scrambled so that only the sender and recipient can see them. If anyone else intercepts the message, all they will see is garble that can't be unscrambled without the key. Law enforcement officials had until now resisted this type of encryption because it means the technology companies themselves won't be able to look at the messages, nor respond to law enforcement requests to turn the data over. Here's a look at various ways ordinary consumers can use end-to-end encryption: Officials said the hackers targeted the metadata of a large number of customers, including information on the dates, times and recipients of calls and texts. They also managed to see the content from texts from a much smaller number of victims. If you're an iPhone user, information in text messages that you send to someone else who also has an iPhone will be encrypted end-to-end. Just look for the blue text bubbles, which indicate that they are encrypted iMessages. The same goes for Android users sending texts through Google Messages. There will be a lock next to the timestamp on each message to indicate the encryption is on. But there's a weakness. When iPhone and Android users text each other, the messages are encrypted only using Rich Communication Services, an industry standard for instant messaging that replaces the older SMS and MMS standards. Apple has noted that RCS messages “aren’t end-to-end encrypted, which means they’re not protected from a third party reading them while they’re sent between devices.” Samsung, which sells Android smartphones, has also hinted at the issue in a footnote at the bottom of a press release last month on RCS, saying, “Encryption only available for Android to Android communication.” To avoid getting caught out when trading texts, experts recommend using encrypted messaging apps. Privacy advocates are big fans of Signal, which applies end-to-end encryption to all messages and voice calls. The independent nonprofit group behind the app promises never to sell, rent or lease customer data and has made its source code publicly available so that it can be audited by anyone to examine it “for security and correctness.” Signal's encryption protocol is so reputable that it has been integrated into rival WhatsApp, so users will enjoy the same level of security protection as Signal, which has a much smaller user base. End-to-end encryption is also the default mode for Facebook Messenger, which like WhatsApp is owned by Meta Platforms. Telegram is an app that can be used for one-on-one conversations, group chats and broadcast “channels" but contrary to popular perception, it doesn't turn on end-to-end encryption by default. Users have to switch on the option. And it doesn’t work with group chats. Cybersecurity experts have warned people against using Telegram for private communications and pointed out that only its opt-in ‘secret chat’ feature is encrypted from end-to-end. The app also has a reputation for being a haven for scammers and criminal activity, highlighted by founder and CEO Pavel Durov's arrest in France. Instead of using your phone to make calls through a wireless cellular network, you can make voice calls with Signal and WhatsApp. Both apps encrypt calls with the same technology that they use to encrypt messages. There are other options. If you have an iPhone you can use Facetime for calls, while Android owners can use the Google Fi service, which are both end-to-end encrypted. The only catch with all these options is that, as with using the chat services to send messages, the person on the other end will also have to have the app installed. WhatsApp and Signal users can customize their privacy preferences in the settings, including hiding an IP address during calls to prevent your general location from being guessed.
Dylan Hernández: MLS deal with Apple TV could be hurting league's efforts to grow its fan base
Lewis scores 18 as Toledo knocks off Defiance 111-49